NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Merge Healthcare Incorporated (“Merge” or the “Company”) (NASDAQ:MRGE) for potential breaches of fiduciary duties in connection with the sale of the Company to IBM for approximately $1 billion in a cash transaction. The Company’s stockholders will only receive $7.13 for each share of Company common stock they own. However, the offer r
| < Prev | Next > |
|---|
